- Home
- NVMI vs BBIO Comparison
NVMI vs BBIO Comparison
Compare NVMI & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVMI
- BBIO
- Stock Information
- Founded
- NVMI 1993
- BBIO 2015
- Country
- NVMI Israel
- BBIO United States
- Employees
- NVMI N/A
- BBIO N/A
- Industry
- NVMI Electronic Components
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- NVMI Technology
- BBIO Health Care
- Exchange
- NVMI Nasdaq
- BBIO Nasdaq
- Market Cap
- NVMI 6.3B
- BBIO 6.7B
- IPO Year
- NVMI 2000
- BBIO 2019
- Fundamental
- Price
- NVMI $183.61
- BBIO $33.07
- Analyst Decision
- NVMI Strong Buy
- BBIO Strong Buy
- Analyst Count
- NVMI 7
- BBIO 12
- Target Price
- NVMI $250.83
- BBIO $52.64
- AVG Volume (30 Days)
- NVMI 311.8K
- BBIO 2.7M
- Earning Date
- NVMI 05-08-2025
- BBIO 05-01-2025
- Dividend Yield
- NVMI N/A
- BBIO N/A
- EPS Growth
- NVMI 34.30
- BBIO N/A
- EPS
- NVMI 5.75
- BBIO N/A
- Revenue
- NVMI $672,396,000.00
- BBIO $221,902,000.00
- Revenue This Year
- NVMI $28.95
- BBIO $12.42
- Revenue Next Year
- NVMI $6.55
- BBIO $123.19
- P/E Ratio
- NVMI $32.41
- BBIO N/A
- Revenue Growth
- NVMI 29.83
- BBIO 2285.27
- 52 Week Low
- NVMI $158.00
- BBIO $21.62
- 52 Week High
- NVMI $289.90
- BBIO $39.47
- Technical
- Relative Strength Index (RSI)
- NVMI 31.30
- BBIO 51.35
- Support Level
- NVMI $177.87
- BBIO $35.77
- Resistance Level
- NVMI $206.82
- BBIO $37.06
- Average True Range (ATR)
- NVMI 7.55
- BBIO 1.40
- MACD
- NVMI -1.50
- BBIO 0.18
- Stochastic Oscillator
- NVMI 11.73
- BBIO 47.67
Stock Price Comparison Chart: NVMI vs BBIO
About NVMI Nova Ltd.
Nova Ltd is a semiconductor equipment manufacturer. The company provides metrology solutions for process control used in semiconductor manufacturing. The company offers in-line optical and x-ray stand-alone metrology systems, as well as integrated optical metrology systems. The product range consists of Nova 2040, Nova 3090Next, Nova i500 and i500 Plus, Nova T500, Nova T600, Nova V2600, HelioSense 100, Nova Hybrid Metrology solution, NovaMars. The company generates the majority of its revenue from China. Geographically the company has its business spread across the region of Taiwan, Korea, China, the United States, and Europe.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.